Pre- & Postnatal Health

During the last three months of pregnancy, the infant’s brain receives a continuous supply of polyunsaturated fatty acids, DHA in particular. These fatty acids are essential to the development of the brain function and visual function. The supply of fatty acids continues during the first year of life, and it is therefore essential that the mother has a regular intake of a DHA-enriched food or supplements during the last part of pregnancy and while breastfeeding.

Studies have demonstrated that infants given Omega-3-fortified formula show better intellectual development and visual acuity than infants given standard formula without Omega-3 fatty acids. The same applies to infants breast fed by mothers with a regular intake of seafood or marine Omega-3 supplements.

Marine-based EPAX 1050 TG provides the perfect supplement to support pre- and postnatal health.


Click here to see articles about Omega-3 and Pre-and Postnatal Health

 
 

EPAX 1050 TG

60 mg/g EPA
430 mg/g DHA

EPAX 1050 TG Specification
 EPAX 1050 TG Nutritional values

 

 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com